I once worked for a company that was specifically targeted by an industry group for coordinated attacks and anti-competitive tactics. We obtained a copy of the agenda for the planning meeting for this onslaught, and the bullet points looked like part of a hypothetical in an anti-trust class law school exam. This was the most blatant collusion in restraint of trade imaginable. But the lawyers for the group apparently thought all could be made benign and legal by a disclaimer on every agenda copy that said, in effect, “Don’t pay any attention to what this agenda says—trust us, it’s all fair and legal.” The disclaimer stated that the organization fully supported and followed all provisions of U.S. anti-trust statutes, and would never, ever do anything to violate them. This is roughly the equivalent of a mugger telling his victim that he is non-violent while he’s punching him in the face.
I am reminded of that agenda when I see commercials for new drugs, which show healthy, happy, beautiful models frolicking with their families or lovers in idyllic settings while the announcer, usually at breakneck speed, warns that the drug may cause violent flatulence, boils, locusts, insanity, cannibalism and excruciating death. I was reminded of the agenda again when I learned of the latest gambit by PublishAmerica, which earlier this year got in trouble with “Harry Potter” author J.K. Rowling by soliciting money from authors by promising to bring their works to her attention: Continue reading
